Overview

Methylphenidate Treatment for Cocaine Abuse and ADHD - 1

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
Many cocaine dependent individuals are also diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate (Ritalin) is currently approved to treat individuals diagnosed with ADHD. The purpose of this study is to determine the effectiveness of methylphenidate in treating ADHD symptoms in cocaine dependent individuals.
Phase:
Phase 1
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Methylphenidate